These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1511 related items for PubMed ID: 24261228
1. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)]. Chazova IE, Martynyuk TV. Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228 [Abstract] [Full Text] [Related]
2. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I. Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [Abstract] [Full Text] [Related]
6. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL. Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [Abstract] [Full Text] [Related]
7. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Jamerson KA, Nwose O, Jean-Louis L, Schofield L, Purkayastha D, Baron M. Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521 [Abstract] [Full Text] [Related]
8. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine. Ferri C, Croce G, Desideri G. Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492 [Abstract] [Full Text] [Related]
10. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R. Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280 [Abstract] [Full Text] [Related]
11. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing. Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455 [Abstract] [Full Text] [Related]
12. Amlodipine/valsartan single-pill combination: a prospective, observational evaluation of the real-life safety and effectiveness in the routine treatment of hypertension. Karpov Y, Dongre N, Vigdorchik A, Sastravaha K. Adv Ther; 2012 Feb; 29(2):134-47. PubMed ID: 22271158 [Abstract] [Full Text] [Related]
17. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy. Malesker MA, Hilleman DE. Manag Care; 2010 Jul; 19(7):36-42. PubMed ID: 20672530 [Abstract] [Full Text] [Related]
18. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y. Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480 [Abstract] [Full Text] [Related]
19. [Possibilities of rational combination antihypertensive therapy: results of HEMERA international clinical trial]. Chazova IE, Martyniuk TV. Ter Arkh; 2013 Jul; 85(10):10-22. PubMed ID: 24437213 [Abstract] [Full Text] [Related]